rivaroxaban

A spokesman for Bayer HealthCare in Berlin said the German pharmaceutical and chemicals company still expects Xarelto, also known by its chemical name rivaroxaban, to eventually generate peak sales of more than €2 billion $2.87 billion annually.

Rival Drug Success Pressures Bayer Sten Stovall 2011

The study included 14,264 patients in 45 countries taking either Xarelto, generically called rivaroxaban, or warfarin.

FDA Panel Backs Xarelto for Stroke Prevention Thomas M. Burton 2011

Xarelto, also known as rivaroxaban, is already approved in Europe for use in certain surgery patients.

EU Backs Bayer's Blood Thinner Natascha Divac 2011

On Monday, researchers reported results from a 14,264-patient study that a drug called rivaroxaban performed at least as well as warfarin in preventing strokes and averting catastrophic bleeding complications in patients with a heartbeat irregularity called atrial fibrillation.

New Heart Medications Gain Clout Ron Winslow 2010

The panel's decision on rivaroxaban, which is sold under the brand name Xarelto in Europe, amounts to a recommendation that the agency approve the product.

FDA Panel Backs J&J, Bayer Drug 2009

The drug, also known by the generic name rivaroxaban, received the green light Friday from the European Medicines Agency's Committee for Medicinal Products for Human Use.

Potential Blockbuster 2008

The study actually called rivaroxaban "noninferior" to warfarin, a double negative that must have made executives at Johnson & Johnson, parent of rivaroxaban, want to weep.

NPR Topics: News 2011

A new drug called rivaroxaban may not require as many blood tests for patients with atrial fibrillation than the current drug on the market.

NPR Topics: News 2011

Now, researchers say a new drug called rivaroxaban looks to be as good as warfarin in preventing strokes.

NPR Topics: News 2011

Panelists were divided on whether Xarelto, with the clinical name rivaroxaban, was as effective as warfarin.

Reuters: Press Release 2011